Literature DB >> 8173373

How can hospitals ration drugs? Drug rationing in a teaching hospital: a method to assign priorities. Drug Committee of the Royal Adelaide Hospital.

F Bochner1, E D Martin, N G Burgess, A A Somogyi, G M Misan.   

Abstract

Keywords:  Health Care and Public Health; Professional Patient Relationship; Royal Adelaide Hospital (Australia)

Mesh:

Year:  1994        PMID: 8173373      PMCID: PMC2539814          DOI: 10.1136/bmj.308.6933.901

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  30 in total

1.  Priorities in health care: reply to Lewis and Charny.

Authors:  David Lamb
Journal:  J Med Ethics       Date:  1989-03       Impact factor: 2.903

2.  Rationing.

Authors:  C Heginbotham
Journal:  BMJ       Date:  1992-02-22

3.  Clinical decision making: from theory to practice. Cost-effectiveness analysis. A conversation with my father.

Authors:  D M Eddy
Journal:  JAMA       Date:  1992-03-25       Impact factor: 56.272

4.  Clinical decision making: from theory to practice. Cost-effectiveness analysis. Is it up to the task?

Authors:  D M Eddy
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

5.  Warning signals from Oregon.

Authors:  R Klein
Journal:  BMJ       Date:  1992-06-06

6.  Rationing: the search for sunlight.

Authors:  R Smith
Journal:  BMJ       Date:  1991 Dec 21-28

7.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Authors:  A Laupacis; D Feeny; A S Detsky; P X Tugwell
Journal:  CMAJ       Date:  1992-02-15       Impact factor: 8.262

8.  Economics, health, and the economics of health.

Authors:  C Normand
Journal:  BMJ       Date:  1991 Dec 21-28

9.  Rationing.

Authors:  N Chaturvedi
Journal:  BMJ       Date:  1993-02-06

10.  Health care technology and the inevitability of resource allocation and rationing decisions. Part II.

Authors:  R W Evans
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

View more
  15 in total

1.  Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.

Authors:  R Fijn; L T de Jong-van den Berg; J R Brouwers
Journal:  Pharm World Sci       Date:  1999-04

2.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

3.  Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.

Authors:  R Fijn; S A Engels; J R Brouwers; R J Knaap; L T De Jong-Van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

4.  Hospital prescribing errors: epidemiological assessment of predictors.

Authors:  R Fijn; P M L A Van den Bemt; M Chow; C J De Blaey; L T W De Jong-Van den Berg; J R B J Brouwers
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

Review 5.  Drug rationing in the UK National Health Service. Current status and future prospects.

Authors:  T Walley; A Haycox; S Barton
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

6.  Indicators for drug and therapeutics committees.

Authors:  L M Weekes; C Brooks; R O Day
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

7.  Approaches to rationing drugs in hospitals. An Australian perspective.

Authors:  F Bochner; N G Burgess; E D Martin
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 8.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 9.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

10.  A purchaser perspective of managing new drugs: interferon beta as a case study.

Authors:  T Walley; S Barton
Journal:  BMJ       Date:  1995-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.